Your shopping cart is currently empty

Etersalate inhibits platelet function. It also reduces thromboxane A2 (TXA2) levels.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | Etersalate inhibits platelet function. It also reduces thromboxane A2 (TXA2) levels. |
| In vitro | Etersalate, at lower doses, both inhibits platelet function and reduces thromboxane A2 (TXA2) levels, while simultaneously stimulating prostaglandin I2 (PGI2) generation in aortic rings from rats treated with plasma from Etersalate-administered donors. Blood coagulation metrics remain unaffected. The study explores Etersalate's ex vivo antiplatelet effects and its influence on serum TXA2 levels and PGI2 production in human volunteers across two dosages. Distinctively, Etersalate impacts platelet arachidonate metabolism through a mechanism separate from the cyclooxygenase pathway. |
| Synonyms | Etherylate, Eterylate |
| Molecular Weight | 357.36 |
| Formula | C19H19NO6 |
| Cas No. | 62992-61-4 |
| Smiles | O(C(C)=O)C1=C(C(OCCOC2=CC=C(NC(C)=O)C=C2)=O)C=CC=C1 |
| Relative Density. | 1.263 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.